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BACKGROUND:  Transient  hypertension  (TH)  and  pre-
eclampsia (PE) are believed to have different patho-
physiology.  However,  15–25%  of  pregnant  women
initially diagnosed as having TH develop PE. To clarify
the immuno-pathogenetical connections between the
two syndromes, we studied the pattern of T helper
cell (Th)1/Th2 cytokine balance disturbances existing
inside maternal decidua in normal pregnancy (NP)
and pregnancies complicated with TH and PE.
Methods:  Third-trimester  decidual  tissue  was
obtained by curettage of uterine cavity during elective
caesarean sections in NP (n = 11), TH (n = 17) and PE
(n = 21) patients. Cell suspensions were prepared by
an  electromechanical  dispersal  method  and  cen-
trifugated  using  a  standard  gradient  sedimentation
technique.  Isolated  lymphocytes  were  placed  in
medium  (RPMI  1640,  10%  fetal  calf  serum,
L-glutamine,  penicillin,  streptomycin)  and  cultured
for 72h with or without mitogen phytohaemagluti-
nine  (PHA).  The  enzyme-linked  immunosorbent
assay method was used for estimation of interleukin
(IL)-2, IL-4, IL-6, IL-10, IL-12 and interferon-g (IFNg ) in
culture supernatant.
Statistical  analysis:  The  Kruskal–Wallis  and  the
Mann–Whitney U tests were used (p < 0.05).
Results: Both spontaneous and PHA-stimulated secre-
tion  of  Th2-type  cytokines  IL-6  and  IL-10  was
decreased in PE patients compared with TH and NP
patients.  The  concentration  of  Th1-type  cytokine
IFNg was increased in patients suffering both from
TH and PE.
Conclusion: On the base of decidual cytokine secre-
tion, both PE and TH are syndromes of local Th1/Th2
cytokine balance disturbances as compared with NP,
and TH seems to be an intermediate step to PE.
Key words: Lymphocyte, Cytokine, Decidua, Pre-eclamp-
sia, Transient hypertension
Introduction
Although the clinical presentations of pre-eclampsia–
eclampsia and transient hypertension of pregnancy at
least partially overlap, opinion exists that they are two
distinct  conditions1 with  different  pathophysiol-
ogy2–5and outcome.6 However, epidemiological anal-
ysis indicates that approximately 15–25% of pregnant
women initially diagnosed as having transient hyper-
tension develop fully symptomatic pre-eclampsia later
in  pregnancy.7 This  means  that,  in  some  patients,
transient hypertension could probably  represent an
intermediate step in progression to pre-eclampsia.
The  involvement  of  abnormal  activation  of  the
innate and acquired immune system in the pathogene-
sis  of  pre-eclampsia  is  well  documented.8,9 The
elevated  serum  level  of  interleukin  (IL)-12,10 fetal
monocyte activation9 and deficiency of placental IL-
10  production11 are  responsible  for  enhanced  T
helper  (Th)1-type  cell  maturation  and  hampered
immunological tolerance of pre-eclamptic women to
the foreign antigens of the fetus. The existence of a
superantigen-like  effect  in  a  subset  of  patients12
supports  the  idea  of  the  immunopathogenetical
background of pre-eclampsia.
A widely accepted hypothesis originally presented
by Wegman et al.13 underlines the crucial role of Th2-
activity cytokines in promoting successful pregnancy.
Since that time, existence of the ‘Th2-phenomenon’
during normal human pregnancy has been confirmed
by many authors.14–18 Pre-eclampsia is accompanied
with elevated serum levels of Th1-type cytokines IL-
1210 and tumor necrosis factor-a(TNFa),19 as well as
Th2-type cytokine IL-6.19 Upregulation of Th1-activity
responses  was  also  shown ‘in  vitro’  by  increased
interferon-g (IFNg),14 IL-2 and TNFa14,20 production
by  peripheral  blood  lymphocytes.  IL-2  and  IL-12
stimulate Th1-like cell maturation21,22 and TNFa may
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observed  in  pre-eclampsia.19 The  predominance  of
Th1-type activity was accompanied by the effect of
decreased Th2-type suppressory cytokine IL-10 secre-
tion by peripheral blood lymphocytes ‘in vitro’20 as
well  as  in  placental  samples.11 The  investigations
performed during pregnancy complicated with pre-
eclampsia  indicated  that  disturbances  of  cytokine
Th1/Th2 balance are associated with elevated endo-
thelin-1  levels  followed  by  the  presence  of
hypertension.23
None of the aforementioned studies refered to the
autocrine pattern of Th1/Th2 cytokine balance inside
maternal  decidua  in  pre-eclampsia  and  transient
hypertension,  and  their  potential  role  in  under-
standing  the  local  regulatory  mechanisms  seen  in
those two syndromes. To clarify this subject, we have
focused our attention on comparison between spon-
taneous and mitogen-stimulated production of IL-2, IL-
4, IL-6, IL-10, IL-12 and IFNg in cultured lymhocytes
isolated  from  third  trimester  decidua  of  healthy
pregnant women, pre-eclamptics and those pregnant
with  transient  hypertension.  The  obtained  results
have suggested that disturbances in autocrine regula-
tion may be decisive for disease outcome.
Materials and methods
Patients
The study group was chosen from pregnant women
who  were  hospitalized  between  September  1998
and January 2001 in three departments: the Depart-
ment of Materno-Fetal Medicine, the Department of
Perinatology and the  Department of  the Obstetrics
of Polish Mother’s Health Center Research Institute,
Lodz, Poland.
Inclusion  criteria  were  normal  pregnancy,  and
pregnancy complicated with transient hypertension
or pre-eclampsia. Pre-eclampsia was characterized by
an  increase in  systolic  pressure  of  30mmHg  or  of
diastolic pressure of 15mmHg compared with blood
pressure  measurements  obtained  before  20  gesta-
tional  weeks  (or,  if  these pressure  levels  were  not
known, a blood pressure of 140/90mmHg or greater
obtained in two consecutive measurements 6h apart
after 20 gestational weeks), with concurrent protei-
nuria  greater  than  0.3g  per  24h  or  greater  than
30mg/dl in a specimen. Transient hypertension was
characterized by the same blood pressure measure-
ments  but  without  proteinuria  or  with  proteinuria
less than 0.3g per 24h.1
Exclusion  criteria  were  diabetes  mellitus,  gesta-
tional diabetes mellitus, renal diseases, chronic hyper-
tension that predated pregnancy, infectious diseases
recognized in the course of pregnancy, presence of
premature  or  full-term  uterine  contractions,  pre-
mature  rupture  of  membranes  or  clinical  chor-
ioamnionitis. The pregnant women were not treated
with  corticosteroids before  inclusion  for  the  study.
Establishment  of  such  a  wide  range  of  exclusion
criteria  allowed  us  to  eliminate  possible  clinical
situations that could have a strong impact either on
the composition of decidual lymphocytes or on the
pattern of cytokine secretion.
Finally, 49 pregnant women were chosen for the
study  and,  in  all  cases,  the  selection  was  made
before decidual material was collected. All  of  them
had been qualified for elective caesarean sections. In
this  group,  11  pregnant  women  had  normal  preg-
nancy (controls), 17 presented with transient hyper-
tension  of  pregnancy  and  21  with  pre-eclampsia.
Some  of  the  data  characterizing  each  group  are
presented in Table 1.  In  the group of controls, the
indications for elective caesarean sections were reti-
nal  degeneration  changes,  serious  cardiac  defects,
pelvic deformations, cerebral vessels malformations,
multifetal pregnancy and breech position in women
with high-risk pregnancy. In the group of transiently
hypertensive  patients  the  most  common  indication
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Table 1. Data from routine interview, clinical investigation, blood pressure measurements and laboratory testing in healthy
pregnant women, and pregnant patients with transient hypertension and pre-eclampsia
Parameter Normal
pregnancy
(n = 11)
Transient
hypertension
(n = 17)
Pre-eclampsia
(n = 21)
Patient age (years) 29.5 ± 5.7 28.6 ± 5.3 28.7 ± 6.1
Gestational age (weeks) 36.5 ± 4.9 35.1 ± 3.5 33.3 ± 2.7
Primigravidae (n) 8 13 16
Mean systolic pressure (mmHg) 127.0 ± 7.8 171.9 ± 15.8 178.5 ± 21.9
Mean diastolic pressure (mmHg) 78.7 ± 7.7 107.1 ± 10.8 111.6 ± 12.3
Proteinuria (mg/dl) – 28.3 ± 2.9 509.9 ± 851.7
Proteinuria/24h (g/24h) – – 4.9 ± 6.1
Serum uric acid (mg/dl) 3.8 ± 1.3 5.7 ± 2.0 7.0 ± 1.9
Platelet count (G/l) 235.7 ± 43.8 208.8 ± 40.9 204.7 ± 55.6
Serum aspargin aminotransferase (IU/l) 27.9 ± 4.1 40.7 ± 19.8 54.5 ± 30.8
Serum alanin aminotransferase (IU/l) 17.4 ± 15.2 27.6 ± 13.2 62.4 ± 55.2
Data presented as mean ± standard deviation.was  severe  hypertension  complicated  with  cardio-
tocographic  signs  of  fetal  distress,  while  in  pre-
eclamptic patients the indications were symptoms of
imminent eclampsia and/or cardio-tocographic signs
of  threaten fetal asphyxia. All patients gave written
and  informed  consent  for  participation  in  clinical
research and  the  agreement of the Polish Mother’s
Health  Center Research Institute  Ethical  Commitee
for performing  the study  was obtained.
Cell isolation
Third-trimester maternal decidual tissue was obtained
by  curettage  of  uterine  cavity  during  caesarean
sections. The blood clots and fragments of the fetal
membranes  were  removed  macroscopically  using
sterile pincers. Then the samples were placed into
bottles  containing  sterile  phosphate-buffered  saline
(PBS)  (WSS, Lublin,  Poland). Some of  the collected
samples after initial washing in PBS were randomly
submitted  to  histopathological  examination,  which
revealed that trophoblastic villi were present in less
than 5% of the specimen volume, giving the certainty
that samples contained almost pure decidua. Inside
laminar  flow  cabinet  decidual  slices  were  rinsed
several  times  in  PBS to  remove  residual  blood  and
than  mechanically  disaggregated  to  fragments  of
approximately 3–10mm3 volume. Subsequent decid-
ual  cell  suspensions  were  prepared  by  an  electro-
mechanical  dispersal  method  using  Medimachine
(Dako,  Copenhagen,  Denmark).  Tissue  fragments
with  1.5ml  PBS  were  placed  in  the  Medicon  dis-
aggregator chamber (Dako) with 50mm of separator
mesh. The optimal time of disaggregation was 20sec.
Cell suspensions were filtered using disposable sterile
Filcon (Dako) with a 50–70mm pore size range and
washed  twice  to  eliminate  cell  debris.  To  isolate
lymphocytes,  cell  suspensions  were  centrifugated
using the standard gradient sedimentation technique
on Gradisol G (Polfa, Kutno, Poland). Isolated lympho-
cytes were washed and suspended in PBS in a final
density of 1.0 ´ 105cells/ml. The viability of the cells
in  suspension  was  about  98%,  as  tested  with  the
trypan-blue exclusion method.
Lymphocyte subset analysis
Monoclonal antibodies labeled with fluorescein iso-
thiocyanate (FITC) or phycoerytrin (PE) were used in
the  study.  One-color  or  two-color  immunofluores-
cence staining  was  performed  with  the  use  of  the
following antibodies (Becton-Dickinson, San Jose, CA,
USA): anti-CD3 (against mature T lymphocytes), anti-
CD19 (against B lymphocytes), anti-CD4/CD8 (against
helper/inducer  and  suppressor/cytotoxic  lympho-
cytes),  and  anti-CD56/CD16  (against  natural  killer
(NK)  cells).  Flow  cytometry  was  performed  on
FACSCalibur (Beckton-Dickinson) with a 488nm argon
laser. Optimal scatter gates were set using LeucoGATE
(anti-CD45 FITC and anti-CD14 PE; Becton-Dickinson)
so that analysis gate for cells included more than 96% of
lymphocytes and less than 3% of monocytes/granulo-
cytes.  For  background  control,  immunoglobulin
(Ig)G1 FITC and IgG2a PE (Becton-Dickinson) were
used. No less than 1 ´ 104cells were measured in each
analysis. The results are presented as the percentage of
positive cells in the tested sample.
Cytokine production
Isolated  decidual  lymphocytes  (1.0 ´ 105 cells/ml)
were placed in culture medium: RPMI 1640  (Flow)
enriched with 10% fetal calf serum (Sigma, St Louis,
MO,  USA),  2 mM  L-glutamine  (Serva,  Heidelberg,
Germany),  and  antibiotics  (100U/ml  of  penicillin,
10mg/ml of streptomycin). To stimulate lymphocyte
proliferation, phytohaemaglutinine (PHA) (Sigma) in a
concentration of 5mg/ml of culture medium was used.
Cultures were conducted in flat-bottomed microplates
(Nunc, Kamstrupvij, Denmark) using 105 cells/100ml
of medium, for 72h in humidified air with 5% CO2
(Assab,  Stockholm,  Sweden),  and  each  experiment
carried out  in  triplicate.  Control triplicates  had no
mitogen added. At the end of the culture, microplates
were centrifugated at 2000 ´ g for 10min. Then the
culture supernatant was collected and frozen at –80°C.
A standard immunoenzymatic enzyme-linked immuno-
sorbent assay method was used for estimation of IL-2,
IL-6, IL-10, IL-12, IFNg (ENDOGEN, Minneapolis, MN,
USA) and IL-4 (Hybridomus; Cytotech, Copenhagen,
Denmark) concentrations.  The results are presented as
picograms per milliliter. The minimal detection limits
for  cytokines  were  as  follows:  <  6pg/ml  for  IL-2,
1.1pg/ml for IL-4, < 1pg/ml for IL-6, < 3pg/ml for IL-
10, < 5pg/ml for IL-12, and < 2pg/ml for IFNg. Intra-
assay and inter-assay coefficients of variation for all
studied cytokines were < 10%.
Statistical analysis
Results are reported as the group median with cut-off
points  of  25%  and  75%  of  results.  Analysis  of
differences between three groups was initially carried
out using  the  Kruskal–Wallis  test. Than the  Mann–
Whitney  U  test  (p <  0.05)  was  performed  as
appropriate to test for the statistical significance of
differences  between  each  pair  of  groups. We  used
licensed Statistica 5.0 for Windows.
Results
The  examples  of  the  main  maternal  lymphocyte
subsets obtained during isolation from third-trimester
decidual tissue are presented in Table 2. Pre-eclamptic
patients, compared with controls and those pregnant
and with transient hypertension, were characterized
with  significantly  increased  percentage  of  classical
Cytokine secretion by decidual lymphocytes in TH and PE
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of mature CD3+T and CD19+ B lymphocytes.
The concentrations of  cytokines secreted sponta-
neously to supernatant of cultured decidual lympho-
cytes are compared in Table 3 and presented graph-
ically  in  Figs  1,  3,  5,  and  7.  Analysis  indicated
significantly decreased levels of IL-6 and IL-10 in pre-
eclamptic patients as well as increased level of IFNg
in patients suffering from both transient hypertension
and pre-eclampsia.
The concentrations of cytokines secreted on mito-
gen stimulation of cultured decidual lymphocytes are
presented in Table 4 and presented graphically in Figs
2, 4, 6, and 8. Lymphocytes of pre-eclamptic women
secreted significantly decreased amounts of IL-6, IL-10
and IL-12 but extremely increased amounts of IFNg.
J. R. Wilczy´ nski et al.
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Table 2. The percentage of main decidual lymphocyte subsets in the group of healthy pregnant women, and pregnant patients
with transient hypertension and pre-eclampsia
Decidual
lymphocyte
subsets (%)
(1) Normal
pregnancy
(n = 11)
(2) Transient
hypertension
(n = 17)
(3) Pre-eclampsia
(n = 21)
p
CD3
+ 58.0
(55.0/62.0)
56.0
(49.0/62.0)
32.0
(26.0/50.0)
(1)–(2), NS
(1)–(3), < 0.0004
(2)–(3), < 0.0006
CD19
+ 3.0
(2.0/5.0)
3.0
(2.0/4.0)
1.0
(1.0/2.0)
(1)–(2), NS
(1)–(3), < 0.02
(2)–(3), < 0.005
CD4
+ 25.0
(22.0/28.0)
26.0
(24.0/31.0)
19.0
(13.0/26.0)
(1)–(2), NS
(1)–(3), NS
(2)–(3), NS
CD8
+ 26.0
(24.0/30.0)
23.0
(20.0/28.0)
26.0
(24.0/36.0)
(1)–(2), < 0.04
(1)–(3), NS
(2)–(3), < 0.05
NK cells 35.0
(32.0/38.0)
24.0
(20.0/33.0)
57.0
(45.0/62.0)
(1)–(2), < 0.02
(1)–(3), < 0.002
(2)–(3), < 0.00003
Data presented as median (25%/75%). CD3+, Lymphocyte T; CD19+, lymphocyte B; CD4+, helper/inducer lymphocytes; CD8+, suppressor/cytotoxic
lymphocytes; NK cells, classical natural killer CD3–/CD56+CD16+ cells; NS, difference statistically unsignificant.
Table  3.  Spontaneous  cytokine  secretion  (pg/ml)  from  cultured  decidual  lymphocytes  of  normal  pregnant  women,  and
pregnant patients with transient hypertension and pre-eclampsia
Cytokine (1) Normal
pregnancy
(n = 11)
(2) Transient
hypertension
(n = 17)
(3) Pre-eclampsia
(n = 21)
p
IL-2 0.0
(0.0/0.0)
0.0
(0.0/5.9)
0.0
(0.0/0.0)
(1)–(2), NS
(1)–(3), NS
(2)–(3), NS
IL-4 0.0
(0.0/0.0)
0.0
(0.0/0.0)
0.0
(0.0/0.0)
(1)–(2), NS
(1)–(3), NS
(2)–(3), NS
IL-6 1661.5
(1115.0/1957.0)
1454.2
(1165.0/4090.0)
720.0
(111.2/1147.0)
(1)–(2), NS
(1)–(3), < 0.002
(2)–(3), < 0.0008
IL-10 115.0
(53.3/267.5)
128.5
(9.4/394.0)
41.0
(12.5/89.0)
(1)–(2), NS
(1)–(3), < 0.05
(2)–(3), NS
IL-12 16.0
(0.0/17.8)
12.0
(3.3/16.9)
12.5
(0.0/23.7)
(1)–(2), NS
(1)–(3), NS
(2)–(3), NS
IFNg 0.0
(0.0/0.5)
7.6
(0.0/35.4)
3.9
(0.0/21.0)
(1)–(2), < 0.03
(1)–(3), 0.05
(2)–(3), NS
Data presented as median (25%/75%). NS, Difference statistically unsignificant.Discussion
Our  study,  in  concordance with previous investiga-
tions performed on cultured peripheral blood mono-
nuclear cells (PBMCs),14,20 revealed that also lympho-
cytes isolated from decidua of pre-eclamptic patients
are  capable  of  producing,  spontaneously  and  after
PHA stimulation, large amounts of IFNg. IFNg belongs
to cytokines of strong Th1-like activity and is mainly
produced by T lymphocytes and  activated decidual
NK  cells.22 Because  PHA  is  believed  to  exert  its
mitogenic  effects  mainly  on  T  lymphocytes,  it  is
possible that increased levels of IFNg origin from NK
cells activated vigorously by intercellular regulatory
signals  sent by T  cells.  Increased concentrations of
this cytokine are harmful for pregnancy, causing fetal
resorptions in  the mice model of  recurrent sponta-
neous abortions,24 and could also be responsible for
induction of trophoblast apoptosis.25 Decreased IFNg
production by PBMCs was noted in pregnant women
in remission of rheumatoid arthritis.26 Of all investi-
gated cytokines, only IFNg is significantly increased
when patients with transient hypertension are com-
pared with normotensive pregnant controls. Despite
the  lack  of  changes  concerning  the  rest  of  the
investigated cytokines, this result indicates the pres-
ence of a prominent local Th1 shift27,28 in transient
hypertension similar to that existing in pre-eclampsia.
The diminished production of IL-6 and IL-10 observed
in  our  study  indicates  downregulation  of Th2-type
activity in decidual tissue, which is supplementary to
that observed in  peripheral blood20 and  placenta29
during  pre-eclamptic  pregnancy,  and  may  result  in
IFNg overproduction.  Deficiency  in  IL-6  secretion
observed during pre-eclampsia lowers trophoblastic
hCG production and causes defective placental devel-
opment.25 Lowered IL-10 production in pre-eclampsia
could be  associated with heightened maternal anti-
foetal  immunity  and  inadequate  placental  develop-
ment.11IL-12 promotes the potential of CD4 T cells to
produce IFNg; however, decreased IL-12 production
does  not  result  in  inhibition  of  IFNg secretion,30
which is confirmed by our results.
Lymphocyte  subset  analysis  indicates  that  the
decidua of pre-eclamptic patients contains increased
numbers  of  classical  NK  cells.  This  remains  in
agreement with results obtained by Stallmach et al.,31
who  found  out  that  in  pre-eclamptic  patients  NK
CD56+ cells  constituted more than 40%  of  decidua
infiltrating cells. The co-existence of a lowered CD3+
T  subset  percentage  together  with  NK  population
shift could be responsible for the observed cytokine
disbalance.32 Very  low  representation  of  decidual
CD19+ B lymphocytes in pre-eclampsia argues against
thesis33 of their possible role in pathogenesis of this
syndrome. The classical NK CD3–/CD56+16+ cells are
more abundant in  the decidua of  healthy  pregnant
subjects  then  in  pregnant  women  with  transient
hypertension. The candidate for local immunoregula-
tory mechanism inhibiting NK proliferation is antigen
HLA-G, whose expression on the trophoblastic sur-
face in the cases of transient hypertension is higher
compared with pre-eclampsia.34
Taking  into  consideration  the  disturbances  of
local cytokine production by decidual lymphocytes
‘in vitro’, we conclude that transient hypertension
Cytokine secretion by decidual lymphocytes in TH and PE
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Table 4. PHA-stimulated cytokine secretion (pg/ml) from cultured decidual lymphocytes of normal pregnant women, and
pregnant patients with transient hypertension and pre-eclampsia
Cytokine (1) Normal
pregnancy
(n = 11)
(2) Transient
hypertension
(n = 17)
(3) Pre-eclampsia
(n = 21)
P
IL-2 565.4
(285.2/802.9)
311.0
(8.6/700.6)
624.0
(316.9/960.8)
(1)–(2), NS
(1)–(3), NS
(2)–(3), NS
IL-4 17.8
(14.8/39.1)
51.5
(21.3/78.6)
30.0
(17.2/48.6)
(1)–(2), 0.06
(1)–(3), NS
(2)–(3), NS
IL-6 7211.0
(6186.0/7990.0)
7559.5
(5930.0/9268.7)
3295.2
(582.0/6416.4)
(1)–(2), NS
(1)–(3), < 0.02
(2)–(3), < 0.002
IL-10 1046.2
(645.6/1548.2)
1015.0
(330.0/1865.0)
282.0
(155.2/680.0)
(1)–(2), NS
(1)–(3), < 0.002
(2)–(3), < 0.008
IL-12 436.6
(151.0/491.2)
209.8
(92.4/417.0)
212.7
(79.6/300.4)
(1)–(2), NS
(1)–(3), < 0.05
(2)–(3), NS
IFNg 2950.3
(1018.9/13249.2)
24850.0
(3105.8/45850.0)
44201.0
(41980.0/76450.0)
(1)–(2), 0.06
(1)–(3), < 0.0002
(2)–(3), < 0.02
Data presented as median (25%/75%). NS, Difference statistically unsignificant.FIG. 1. Comparison of IL-6 spontaneous secretion in healthy
pregnant women (controls) (n = 11), and pregnant women
with transient hypertension (TH) (n = 17) and pre-eclampsia
(PE)  (n =  21).  Statistically  significant  are  the  differences
between controls and PE (p < 0.002) and between TH and PE
(p < 0.0008).
FIG.  2.  Comparison  of  IL-6  PHA-stimulated  secretion  in
healthy pregnant women (controls) (n = 11), and pregnant
women with transient hypertension (TH) (n = 17) and pre-
eclampsia  (PE)  (n =  21).  Statistically  significant  are  the
differences between controls and PE (p < 0.02) and between
TH and PE (p < 0.002).
FIG. 3. Comparison of IL-10 spontaneous secretion in healthy
pregnant women (controls) (n = 11), and pregnant women
with transient hypertension (TH) (n = 17) and pre-eclampsia
(PE)  (n =  21).  Statistically  significant  are  the  differences
between controls and PE (p < 0.05).
FIG.  4.  Comparison  of  IL-10  PHA-stimulated  secretion  in
healthy pregnant women (controls) (n = 11), and pregnant
women with transient hypertension (TH) (n = 17) and pre-
eclampsia  (PE)  (n =  21).  Statistically  significant  are  the
differences between controls and PE (p < 0.002) and between
TH and PE (p < 0.008).
FIG. 5. Comparison of IL-12 spontaneous secretion in healthy
pregnant women (controls) (n = 11), and pregnant women
with transient hypertension (TH) (n = 17) and pre-eclampsia
(PE) (n = 21). The differences between all groups studied are
not statistically significant
FIG.  6.  Comparison  of  IL-12  PHA-stimulated  secretion  in
healthy pregnant women (controls) (n = 11), and pregnant
women with transient hypertension (TH) (n = 17) and pre-
eclampsia  (PE)  (n =  21).  Statistically  significant  are  the
differences between controls and PE (p < 0.05).
FIG. 7. Comparison of IFNg spontaneous secretion in healthy
pregnant women (controls) (n = 11), and pregnant women
with transient hypertension (TH) (n = 17) and pre-eclampsia
(PE) (n = 21). Statistically significant are controls and TH (p <
0.03).
FIG.  8.  Comparison  of  IFNg PHA-timulated  secretion  in
healthy pregnant women (controls) (n = 11), and pregnant
women with transient hypertension (TH) (n = 17) and pre-
eclampsia  (PE)  (n =  21).  Statistically  significant  are  the
differences  between  controls  and  PE  (p <  0.0002)  and
between TH and PE (p < 0.02).
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eclampsia and is like pre-eclampsia characterized by a
disturbed  Th1/Th2  balance,  although  intensity  of
these disturbances is different in each syndrome.
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